Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching.

Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S.

Vasc Health Risk Manag. 2013;9:65-70. doi: 10.2147/VHRM.S39351. Epub 2013 Feb 18.

2.

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study.

Takahashi Y, Nishida Y, Nakayama T, Asai S.

Cardiovasc Diabetol. 2013 Jun 14;12:87. doi: 10.1186/1475-2840-12-87.

3.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
5.

Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel.

Ray JG, Deniz S, Olivieri A, Pollex E, Vermeulen MJ, Alexander KS, Cain DJ, Cybulsky I, Hamielec CM.

BMC Cardiovasc Disord. 2003 May 22;3:3. Epub 2003 May 22.

6.
7.
8.

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.

Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL.

J Am Coll Cardiol. 1999 Dec;34(7):1884-90.

9.

Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.

Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ.

J Am Coll Cardiol. 2000 Sep;36(3):699-705.

10.

Gender differences in hemorheological parameters and in in vitro platelet aggregation in acetylsalicylic acid and clopidogrel treated vascular patients.

Koltai K, Papp J, Kenyeres P, Feher G, Tibold A, Alexy T, Marton Z, Kesmarky G, Toth K.

Biorheology. 2014;51(2-3):197-206. doi: 10.3233/BIR-140661.

PMID:
24898335
12.

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.

Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW.

Circulation. 1999 May 11;99(18):2364-6.

13.

Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke.

Li J, Wang Y, Wang D, Lin J, Wang A, Zhao X, Liu L, Wang C, Wang Y; CHANCE Investigators.

Neurology. 2015 Mar 31;84(13):1330-6. doi: 10.1212/WNL.0000000000001421. Epub 2015 Mar 4.

PMID:
25740863
14.

Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.

Eikelboom JW, Weitz JI, Budaj A, Zhao F, Copland I, Maciejewski P, Johnston M, Yusuf S.

Eur Heart J. 2002 Nov;23(22):1771-9.

PMID:
12419297
15.

Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.

Biller J.

J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19. Review.

PMID:
19380153
16.

Combination antiplatelet agents for secondary prevention of ischemic stroke.

Vande Griend JP, Saseen JJ.

Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Review.

PMID:
18823219
17.

Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.

Keller TT, Squizzato A, Middeldorp S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005158. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD005158.

PMID:
17636787
18.

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S.

Clin Pharmacol Ther. 2003 Mar;73(3):232-41.

PMID:
12621388
19.

Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.

[No authors listed]

Prescrire Int. 2009 Oct;18(103):193-5.

PMID:
19877380
20.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315

Supplemental Content

Support Center